| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Global Medical REIT (GMR) | Wunderlich | $100.00 | n.a. | |||
| United Guaranty (TBA) | J.P. Morgan/ Morgan Stanley | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| TRANSFIRST HOLDINGS (TF) | Goldman Sachs/ J.P. Morgan/ Credit Suisse | $100.00 | n.a. | |||
| New Terms | ||||||
| Aeglea BioTherapeutics (AGLE) | UBS Investment Bank/ BMO Capital Markets/ Wells Fargo Securities | 3.50 | $16.00 | $18.00 | $59.50 | 1-Star |
| Pulse Biosciences (PLSE) | MDB Capital Group/ Feltl and Company | 5.00 | $4.00 | $4.00 | $20.00 | n.a. |
| US Foods Holding (USFD) | KKR | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of March 28, 2016 | Manager(s) | Offered | Raised | Price | 4/1/16 | Change |
| None | ||||||
